Regenerex Pharma, Inc. (RGPX) — 8-K Filings
All 8-K filings from Regenerex Pharma, Inc.. Browse 6 Current Event Report reports with AI-powered summaries and risk analysis.
8-K Filings (6)
- 8-K Filing — May 6, 2026
-
Regenerex Pharma Amends Bylaws, Changes Fiscal Year
— Nov 12, 2025 Risk: low
Regenerex Pharma, Inc. filed an 8-K on November 12, 2025, reporting amendments to its Articles of Incorporation or Bylaws, and a change in its fiscal year. The -
Regenerex Pharma Enters Material Definitive Agreement
— Sep 3, 2025 Risk: medium
Regenerex Pharma, Inc. announced on September 3, 2025, that it has entered into a material definitive agreement. The company, formerly known as Peptide Technolo -
Regenerex Pharma Enters Material Definitive Agreement
— Jul 31, 2025 Risk: medium
On July 31, 2025, Regenerex Pharma, Inc. entered into a material definitive agreement. The company, formerly known as Peptide Technologies, Inc. and Eternelle S -
Regenerex Pharma Reports Director Changes & Compensation Updates
— Apr 2, 2025 Risk: medium
Regenerex Pharma, Inc. filed an 8-K on March 31, 2025, reporting changes in its board of directors and executive compensation arrangements. The filing indicates -
Regenerex Pharma Files 8-K on Officer/Director Changes
— Dec 10, 2024 Risk: medium
Regenerex Pharma, Inc. filed an 8-K on December 10, 2024, reporting changes related to its directors and officers, including elections and appointments. The fil
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX